Document Detail

Reduction of bronchopulmonary dysplasia after participation in the Breathsavers Group of the Vermont Oxford Network Neonatal Intensive Care Quality Improvement Collaborative.
MedLine Citation:
PMID:  17079626     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: The objective of this study was to compare the primary and secondary outcomes of very low birth weight infants before and after participation in the Breathsavers Group of the Vermont Oxford Network-sponsored Neonatal Intensive Care Quality Collaborative. METHODS: Hospitals that participated in the Breathsavers Group contributed clinical data on the outcomes of their very low birth weight infants to the Vermont Oxford Network using standardized clinical definitions, data forms, and inclusion criteria. Outcomes from the last year of the collaborative, 2003, were compared with those from the baseline year, 2001. Models for treatment practices and outcomes measures were adjusted for within-hospital correlation (clustering) and standard risk factors that were present at birth. RESULTS: Bronchopulmonary dysplasia dropped significantly in 2003 compared with the baseline year. Survival improved but not significantly. In addition, severe retinopathy of prematurity, severe intraventricular hemorrhage, and supplemental oxygen at discharge dropped significantly. The use of conventional ventilation at any time during the initial hospitalization, postnatal steroids, and time to first dose of surfactant all decreased significantly. The use of nasal continuous positive airway pressure at any time during hospitalization increased. The use of high-frequency ventilation, delivery room intubation, and surfactant at any time during hospitalization did not change. CONCLUSIONS: The Breathsavers Group improved both clinical care processes and clinical outcomes during the Neonatal Intensive Care Quality Collaborative.
Nathaniel R Payne; Meena LaCorte; Padmani Karna; Song Chen; Marsha Finkelstein; Jay P Goldsmith; Joseph H Carpenter;
Related Documents :
11190706 - Sound and the developing infant in the nicu: conclusions and recommendations for care.
24075206 - Less invasive surfactant administration (lisa) - ways to deliver surfactant in spontane...
2874336 - Death as an option in neonatal intensive care.
15157596 - Palliative care of the infant with lethal anomalies.
842336 - Long-term effect on mother-infant behaviour of extra contact during the first hour post...
8165546 - Extracorporeal life support for the treatment of adult respiratory distress syndrome af...
Publication Detail:
Type:  Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Pediatrics     Volume:  118 Suppl 2     ISSN:  1098-4275     ISO Abbreviation:  Pediatrics     Publication Date:  2006 Nov 
Date Detail:
Created Date:  2006-11-02     Completed Date:  2007-05-09     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0376422     Medline TA:  Pediatrics     Country:  United States    
Other Details:
Languages:  eng     Pagination:  S73-7     Citation Subset:  AIM; IM    
Division of Neonatology, Children's Hospitals and Clinics, 2525 Chicago Ave South, Minneapolis, MN, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adrenal Cortex Hormones / therapeutic use
Bronchopulmonary Dysplasia / epidemiology,  prevention & control*
Cerebral Hemorrhage / epidemiology
Drug Utilization
Infant, Newborn
Infant, Very Low Birth Weight*
Intensive Care, Neonatal / standards*
Outcome and Process Assessment (Health Care)
Oxygen Inhalation Therapy / utilization
Pulmonary Surfactants / therapeutic use
Quality Assurance, Health Care*
Respiration, Artificial / utilization
Retinopathy of Prematurity / epidemiology
United States / epidemiology
Reg. No./Substance:
0/Adrenal Cortex Hormones; 0/Pulmonary Surfactants

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Evaluation and development of potentially better practices to reduce bronchopulmonary dysplasia in v...
Next Document:  Evaluation and development of potentially better practices to improve pain management of neonates.